
Kalderos
Advertisement
Articles by Kalderos




Discarded Drug Refunds in Medicare Part B: What Drug Manufacturers, Providers and Payers Need to Know
ByKalderos
Tuesday, March 22, 2022 11 am CST | 12pm EST | 9am PT | 5pm GMT | 6pm CET There’s less than a year to operationalize discarded drug refunds in Medicare Part B. But with the proper planning and a smart, data-driven approach, your team can minimize implementation challenges and ensure compliant participation.
Advertisement
Latest Updated Articles
Understanding the impact Inflation Reduction Act on stakeholders in drug discount programsPublished: December 1st 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
2
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
3
How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins
4
The Key to Connecting with Patients: Pharma's Market Access Transformation
5
